Pure Global

MAGICL Anti-TSHR - India CDSCO Medical Device Registration

MAGICL Anti-TSHR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000403_ba3a53fd2112d936458324dbef90d21a_406639276e7d41b8137e9e923e8a42bd. This device is marketed under the brand name CLIA. The license holder is M/s. Reckon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
MAGICL Anti-TSHR
UID: IMP/IVD/2019/000403_ba3a53fd2112d936458324dbef90d21a_406639276e7d41b8137e9e923e8a42bd

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

MAGICL Anti-TSHR (CLIA) is intended for the in vitro quantitative determination of antibodies to TSH receptor (CLIA) in human serum or plasma. Clinically, it is mainly used for the auxiliary diagnosis of Graves' disease

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing